110
Participants
Start Date
October 31, 2014
Primary Completion Date
April 18, 2017
Study Completion Date
June 29, 2017
3K3A-APC
3K3A-APC, diluted in 0.9% sodium chloride in water, given as 100 mL IV infusion
Placebo
Matching placebo, 0.9% sodium chloride in water, given as 100 mL IV infusion
Stroke Center, New York
Stroke Center, Buffalo
Stroke Center, Rochester
Stroke Center, Pittsburgh
Stroke Center, Charlottesville
Stroke Center, Nashville
Stroke Center, Columbus
Stroke Center, Cincinnati
Stroke Center, Chicago
Stroke Center, St Louis
Stroke Center, Kansas City
Stroke Center, Dallas
Stroke Center, Salt Lake City
Stroke Center, Los Angeles
Stroke Center, Boston
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Cedars-Sinai Medical Center
OTHER
Massachusetts General Hospital
OTHER
University of Iowa
OTHER
ZZ Biotech, LLC
INDUSTRY